Clinical Trial Update: Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating autologous myoblast grafts for treating ptosis in oculopharyngeal muscular dystrophy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscular Dystrophy Oculopharyngeal
• Ptosis

Snippet

Sponsor: University Hospital, Caen | Conditions: Muscular Dystrophy, Oculopharyngeal, Ptosis | Phase 2, Phase 3 | Status: TERMINATED